Wave Life Sciences to Present at the 29th Annual Credit Suisse Healthcare Conference
CAMBRIDGE, Mass., Nov. 10, 2020 (GLOBE NEWSWIRE) -- Wave Life Sciences Ltd. (Nasdaq: WVE), a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases, announced today that Paul Bolno, MD, MBA, President and Chief Executive Officer, is scheduled to present at the 29th Annual Credit Suisse Healthcare Conference on Wednesday, November 11, 2020 at 5:00 p.m. ET.
A live webcast of the presentation will be available on the Investor Relations page of the Wave Life Sciences corporate website at . A replay of the presentation will be archived and available at that site for 60 days following the event.
About Wave Life Sciences
Wave Life Sciences (Nasdaq: WVE) is a clinical-stage genetic medicines company committed to delivering life-changing treatments for people battling devastating diseases. Wave aspires to develop best-in-class medicines across multiple therapeutic modalities using PRISM, the company’s proprietary discovery and drug development platform that enables the precise design, optimization and production of stereopure oligonucleotides. Driven by a resolute sense of urgency, the Wave team is targeting a broad range of genetically defined diseases so that patients and families may realize a brighter future. To find out more, please visit and follow Wave on Twitter @WaveLifeSci.
Investor Contacts:
Graham Morrell
781-686-9600
Media Contact:
Alicia Suter
617-949-4817
